biocytin has been researched along with quinpirole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gale, SD; Perkel, DJ | 1 |
| Grace, AA; Lin, M; Liu, JJ; Onn, SP | 1 |
| Fields, HL; Hjelmstad, GO; Ishikawa, J; Margolis, EB; Mitchell, JM | 1 |
3 other study(ies) available for biocytin and quinpirole
| Article | Year |
|---|---|
Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
Topics: Action Potentials; Animals; Cholera Toxin; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Finches; Lysine; Male; Neurons; Patch-Clamp Techniques; Quinpirole; Receptors, Dopamine D2; Receptors, Opioid, mu; Substantia Nigra; Tetrodotoxin; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
Dopamine and cyclic-AMP regulated phosphoprotein-32-dependent modulation of prefrontal cortical input and intercellular coupling in mouse accumbens spiny and aspiny neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bicuculline; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; GABA Antagonists; In Vitro Techniques; Lysine; Male; Mice; Mice, Knockout; Neurons; Nucleus Accumbens; Patch-Clamp Techniques; Prefrontal Cortex; Quinpirole; Synaptic Transmission | 2008 |
Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.
Topics: Action Potentials; Amygdala; Analgesics; Animals; Animals, Newborn; Benzeneacetamides; Dopamine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Lysine; Male; Neural Inhibition; Neural Pathways; Neurons; Patch-Clamp Techniques; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2008 |